155 related articles for article (PubMed ID: 35778698)
1. Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
Tatsuguchi A; Yamada T; Ueda K; Furuki H; Hoshimoto A; Nishimoto T; Omori J; Akimoto N; Gudis K; Tanaka S; Fujimori S; Shimizu A; Iwakiri K
BMC Cancer; 2022 Jul; 22(1):723. PubMed ID: 35778698
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
[TBL] [Abstract][Full Text] [Related]
3. Genomic Profiling of Small-Bowel Adenocarcinoma.
Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ
JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
[TBL] [Abstract][Full Text] [Related]
5. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
[TBL] [Abstract][Full Text] [Related]
6. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
7. Driver and targetable alterations in Chinese patients with small bowel carcinoma.
Li J; Li X; Dong N; Yan S; Jing C; Ma T; Li W; Zhang C; Cai Y; Deng W
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6139-6150. PubMed ID: 36680582
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
9. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
[TBL] [Abstract][Full Text] [Related]
11. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
[TBL] [Abstract][Full Text] [Related]
12. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
[TBL] [Abstract][Full Text] [Related]
13. APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum.
Ishizu K; Hashimoto T; Naka T; Yatabe Y; Kojima M; Kuwata T; Nonaka S; Oda I; Esaki M; Kudo M; Gotohda N; Yoshida T; Yoshikawa T; Sekine S
J Gastroenterol; 2021 Nov; 56(11):988-998. PubMed ID: 34514550
[TBL] [Abstract][Full Text] [Related]
14. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
15. Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumors.
Fukusada S; Shimura T; Iwasaki H; Okuda Y; Katano T; Ozeki T; Kitagawa M; Nishie H; Tanaka M; Ozeki K; Kubota E; Tanida S; Kataoka H
Dig Liver Dis; 2022 Jul; 54(7):905-910. PubMed ID: 34961702
[TBL] [Abstract][Full Text] [Related]
16. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
[TBL] [Abstract][Full Text] [Related]
17. Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.
Hida R; Yamamoto H; Hirahashi M; Kumagai R; Nishiyama K; Gi T; Esaki M; Kitazono T; Oda Y
Am J Surg Pathol; 2017 Mar; 41(3):343-353. PubMed ID: 27984236
[TBL] [Abstract][Full Text] [Related]
18. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.
Nakae K; Mitomi H; Saito T; Takahashi M; Morimoto T; Hidaka Y; Sakamoto N; Yao T; Watanabe S
World J Gastroenterol; 2012 Oct; 18(39):5551-9. PubMed ID: 23112547
[TBL] [Abstract][Full Text] [Related]
19. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
20. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.
McIntyre CA; Lawrence SA; Richards AL; Chou JF; Wong W; Capanu M; Berger MF; Donoghue MTA; Yu KH; Varghese AM; Kelsen DP; Park W; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Iacobuzio-Donahue CA; Allen PJ; O'Reilly EM
Cancer; 2020 Sep; 126(17):3939-3949. PubMed ID: 32573775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
